ArticleCurrent opinion in virology2019
Editorial overview: Emerging viruses: interspecies transmission: Expect the unexpected.
Adolfo García-Sastre, Juergen A Richt
Abstract readEditorial
In one paragraphArticle in Current opinion in virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
2 authors.
Adolfo García-SastreIcahn School of Medicine at Mount Sinai, 1468 Madison Avenue, New York, NY 10029, USA. Electronic address: Adolfo.Garcia-Sastre@mssm.edu.
Juergen A RichtKansas State University, College of Veterinary Medicine, Diagnostic Medicine/Pathobiology, K-224B Mosier Hall, Manhattan, KS 66506-5601, USA. Electronic address: jricht@vet.k-state.edu.
Funding
Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KASARSKIS, ANDREW · 2015 to 2021
$46.6MSARS-CoV adaptations through a Systems Biology Lens (SYBIL)U19AI135972 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Adolfo Garcia-Sastre · 2018 to 2026
$27.2MSTRUCTURAL STUDIES IN THE CENTRAL NERVOUS SYSTEMP01AG000001 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 1985 to 2013
$20.7MToward a Universal Influenza Virus VaccineP01AI097092 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2012 to 2022
$17.6MProject I: Immunity to Influenza in Primary Lung Epithelial CellsU19AI117873 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAYOT, FERNAND · 2015 to 2019
$8.6MToward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza virusesR01AI141226 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2017 to 2023
$6.1MSplicing and Nuclear Transport of Influenza Virus mRNAR01AI125524 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COBB, MELANIE H., FONTOURA, BEATRIZ MA · 2016 to 2025
$5.6MInnate Immune Surveillance of HIV-1 During Transmission and Systemic InfectionR01AI127302 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI CHANDA, SUMIT K, GARCIA-SASTRE, ADOLFO · 2017 to 2021
$4.4MCombination Adjuvants to Activate Human Dendritic Cell Subsets and B CellsU01AI124297 · NIAID · JACKSON LABORATORY · PI BANCHEREAU, JACQUES F · 2016 to 2020
$3.8MEarly development of small molecule dendritic cell immunopotentiators for the treatment of solid tumorsR01CA229818 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI CHANDA, SUMIT K, GARCIA-SASTRE, ADOLFO · 2018 to 2021
$2.9MENDOTHELIAL CELL TROPISM IN THE PATHOGENESIS AND HOST RESPONSE AGAINST INFLUENZA VIRUSES - RESUBMISSION 01R01AI127775 · NIAID · UNIVERSITY OF IOWA · PI MANICASSAMY, BALAJI · 2018 to 2022
$2.8MNovel vita-vaccine formula combines safety of dead and efficacy of live vaccinesR01AI127658 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLANDER, JULIE MAGARIAN · 2016 to 2020
$2.1MNCI NIH HHS R01 CA229818NIAID NIH HHS HHSN272201400006CNIAID NIH HHS HHSN272201400008CNIAID NIH HHS P01 AI097092NIAID NIH HHS R01 AI125524NIAID NIH HHS R01 AI127302NIAID NIH HHS R01 AI127658NIAID NIH HHS R01 AI127775NIAID NIH HHS R01 AI141226NIAID NIH HHS R21 AI129486NIAID NIH HHS R21 AI142337NIAID NIH HHS R33 AI119304NIAID NIH HHS U01 AI124297NIAID NIH HHS U19 AI117873NIAID NIH HHS U19 AI118610NIAID NIH HHS U19 AI135972NIA NIH HHS P01 AG000001
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsCommunicable Diseases, EmergingHumansViral VaccinesVirus DiseasesVirusesZoonosesViral Vaccines
Identifiers
PMID30904411
PMCPMC7128631
What OpenQuestion holds
Textmetadata
Read underepoch 390